Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,926 DKK | -4.86% | -5.61% | -10.60% |
May. 21 | Genmab A/S Reaffirms Financial Guidance for 2024 | CI |
May. 21 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.60% | 18.96B | |
+11.92% | 116B | |
+12.99% | 106B | |
-9.14% | 23.89B | |
-1.69% | 21.58B | |
-41.25% | 16.96B | |
-14.54% | 16.33B | |
+6.67% | 14.14B | |
+30.99% | 12.02B | |
-2.17% | 7.58B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab Looks to Expand Clinical Pipeline with $1.8 Billion Purchase of Cancer-focused ProfoundBio